Spero Therapeutics
Laura McGinn is an experienced administrative professional with a robust background in providing executive support within the biotechnology and legal sectors. Currently serving as a Senior Executive Assistant at Spero Therapeutics since 2021, Laura has previously held key positions at Intellia Therapeutics, Akebia Therapeutics, Takeda, Cubist Pharmaceuticals, and law firms such as WilmerHale and Stroock & Stroock & Lavan LLP. The educational foundation includes completion at Fox Lane High School and further studies at Katharine Gibbs in Boston.
This person is not in any teams
Spero Therapeutics
2 followers
Spero Therapeutics (Nasdaq: SPRO) is a multi-asset pre-commercial stage biopharmaceutical company in Cambridge, Mass. We are highly committed to advancing novel treatment approaches for bacterial infections with a world-class team of biotechnological and biopharmaceutical experts. The company has a pipeline of novel and highly differentiated antibacterial and rare disease product candidates focused on patients' unmet needs with multi-drug resistant (MDR) bacterial infections.